Monday, April 6, 2009

The US Generic Drugs Market Overview

The total US generic pharmaceutical manufacturer sales for the year 2007 was$58.5 billion, whereas the sales of branded pharmaceuticals during the same year amounted to $228 billion. In 2009, a number of blockbuster drugs are losing patent protections, some of them include Prevacid, Imigran, Arimidex, Keppra, Cellcept, Flomox, AmbienCR, Valtrex, and Topamax. According to IMS Health, the generic drugs industry is expanding at a growth rate of 7.8%, which faster than the world's market for pharmaceuticals.

Read More at: Themedica

No comments: